Get the Stockscreener App
286.90
0.11%
-0.33
After Hours:
291.00
4.10
+1.43%
Veeva Systems Inc stock is traded at $286.90, with a volume of 1.46M.
It is down -0.11% in the last 24 hours and down -0.38% over the past month.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
See More
Previous Close:
$287.23
Open:
$287.27
24h Volume:
1.46M
Relative Volume:
1.01
Market Cap:
$46.88B
Revenue:
$2.86B
Net Income/Loss:
$780.66M
P/E Ratio:
60.78
EPS:
4.72
Net Cash Flow:
$1.20B
1W Performance:
+0.31%
1M Performance:
-0.38%
6M Performance:
+21.02%
1Y Performance:
+48.17%
1-Day Range:
$284.00
$290.43
1-Week Range:
$284.00
$296.72
52-Week Range:
$177.41
$296.72
Veeva Systems Inc Stock (VEEV) Company Profile
Name
Veeva Systems Inc
Sector
Industry
Phone
925-452-6500
Address
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
286.90 | 46.94B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
57.81 | 10.09B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
98.80 | 8.28B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
58.85 | 11.19B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.64 | 6.18B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-29-25 | Reiterated | Needham | Buy |
| Jan-23-25 | Downgrade | Goldman | Buy → Sell |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-19-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Initiated | Exane BNP Paribas | Outperform |
| Aug-27-24 | Reiterated | Citigroup | Buy |
| Jul-09-24 | Initiated | BTIG Research | Buy |
| Oct-25-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-13-23 | Initiated | Jefferies | Buy |
| Jun-28-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-01-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-17-23 | Downgrade | Truist | Buy → Hold |
| Feb-23-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-04-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-06-22 | Initiated | Cowen | Market Perform |
| Dec-02-22 | Reiterated | Needham | Buy |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-27-22 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | Goldman | Buy |
| Jun-21-22 | Resumed | Guggenheim | Buy |
| Mar-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-28-22 | Initiated | Truist | Buy |
| Jan-07-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-06-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Resumed | Stifel | Buy |
| Sep-02-21 | Reiterated | BofA Securities | Buy |
| Sep-02-21 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-02-21 | Reiterated | Needham | Buy |
| Sep-02-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Initiated | Cowen | Outperform |
| Mar-31-21 | Upgrade | UBS | Sell → Neutral |
| Jan-07-21 | Resumed | KeyBanc Capital Markets | Overweight |
| Dec-09-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-14-20 | Resumed | UBS | Sell |
| Aug-28-20 | Reiterated | Needham | Buy |
| Jul-23-20 | Initiated | FBN Securities | Outperform |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Jun-08-20 | Initiated | Citigroup | Buy |
| May-29-20 | Reiterated | Needham | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-19-20 | Initiated | Robert W. Baird | Outperform |
| Feb-14-20 | Initiated | Piper Sandler | Overweight |
| Jan-13-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-27-19 | Reiterated | Canaccord Genuity | Hold |
| Sep-26-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-28-19 | Reiterated | Needham | Buy |
| Jun-07-19 | Initiated | Goldman | Neutral |
| May-30-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| May-24-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-27-19 | Reiterated | Needham | Buy |
View All
Veeva Systems Inc Stock (VEEV) Latest News
AI Stock With Unique Focus Joins Palantir, Nvidia On 3 Elite Lists - Investor's Business Daily
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality - PR Newswire
Technical Heatmap Flags Veeva Systems Inc. for WatchFast Entry High Potential Stock Alerts Triggered - metal.it
Veeva Systems (NYSE:VEEV) Stock Performs Better Than Its Underlying Earnings Growth Over Last Year - 富途牛牛
Veeva Systems’ SWOT analysis: life sciences leader faces CRM stock battle - Investing.com
Published on: 2025-07-28 23:17:27 - metal.it
What catalysts could drive Veeva Systems Inc. stock higher in 2025Post Market Updates For Consistent Profits - jammulinksnews.com
EssilorLuxottica and Edwards Lifesciences: Accelerating Patient Access: How Technology Speeds Delivery of High-quality Medical Devices - Veeva
Thoughts on Veeva Vault CRM vs. Salesforce CRM for Biopharma - Veeva
Veeva Systems (VEEV) Surpassed Expectations in Q2 - Insider Monkey
Is Veeva Systems Inc. stock overvalued or undervaluedInvest smarter with daily stock recommendations - jammulinksnews.com
When is Veeva Systems Inc. stock expected to show significant growthSkyrocketing returns - jammulinksnews.com
Is it the right time to buy Veeva Systems Inc. stockCapitalize on emerging trends for profits - jammulinksnews.com
Does Veeva Systems Inc. stock perform well during market downturnsAchieve breakthrough gains with smart trades - jammulinksnews.com
How volatile is Veeva Systems Inc. stock compared to the marketCapitalize on momentum-driven stocks - jammulinksnews.com
VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait? - MSN
Is Veeva Systems Inc. a good long term investmentMassive profits - PrintWeekIndia
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know - MSN
Veeva Systems Inc. (VEEV) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
What drives Veeva Systems Inc. stock priceExponential wealth increase - PrintWeekIndia
Veeva Systems Inc. Stock Analysis and ForecastSky-high return potential - Autocar Professional
Veeva Systems (VEEV) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Veeva's Vault Vision: Can It Thrive After Parting With Salesforce? - The Globe and Mail
Veeva Systems stock hits 52-week high at $291.71 - Investing.com
Speed, Scale, and Connectivity: Teva’s New Standard for Medical Information - Veeva
What analysts say about Veeva Systems Inc. stockTurbocharged investment results - jammulinksnews.com
Veeva Vs. Salesforce: Which Life Sciences CRM Stock Is The Better Buy? - Barchart.com
Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy? - The Globe and Mail
Veeva OpenData and Veeva Network Enable Coordinated Customer Engagement for Boehringer Ingelheim - Veeva
Boehringer Ingelheim Standardizes Customer Data with Veeva Across 100 Countries - AInvest
Boehringer Ingelheim adopts Veeva data solutions across 100+ countries By Investing.com - Investing.com Canada
Top 20 Pharma Giant Boehringer Ingelheim Adopts Veeva Platform Across 100+ Countries for AI-Ready Future - Stock Titan
Veeva Systems (VEEV) Gets a Buy from Raymond James - The Globe and Mail
Best Statistical Healthcare Participant Recruitment - openPR.com
Veeva Announces Merck's Commitment to Veeva Vault CRM - AInvest
Veeva Vault CRM Gains Momentum with Top Pharma Companies Committing to Migration - AInvest
Six of top 20 pharma companies committed to Veeva Vault CRM, says Barclays - TipRanks
Veeva's Break from Salesforce: A Strategic Inflection Point for Life Sciences SaaS - AInvest
Veeva Systems (VEEV) Secures Merck Commitment To Enhance Global CRM Capabilities - Yahoo Finance
Veeva Systems Breaks Up With Salesforce, Then Woos Merck - Investor's Business Daily
Merck Adopts Veeva Vault CRM - Contract Pharma
Merck (MRK) Expands Partnership with Veeva Systems for Enhanced CRM Solutions | MRK Stock News - GuruFocus
Merck Commits To Veeva’s Vault CRM, Draws Wall Street Cheer: Retail’s Not Enthusiastic - Stocktwits
Merck Commits to Veeva Vault CRM | VEEV Stock News - GuruFocus
Veeva Systems Inc Stock (VEEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
3.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):